As of April 16, 2025, Health Catalyst (HCAT) has a market cap of $0.26 billion USD. According to our data, Health Catalyst is ranked No.6687 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.26 B |
-39.61%
|
Dec 31, 2024 | $0.43 B |
-23.65%
|
Dec 29, 2023 | $0.56 B |
-12.89%
|
Dec 30, 2022 | $0.65 B |
-73.17%
|
Dec 31, 2021 | $2.41 B |
-8.98%
|
Dec 31, 2020 | $2.65 B |
25.45%
|
Dec 31, 2019 | $2.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Allscripts
MDRX
|
$0.45 B |
0.000 M
|
![]() USA
|
![]() McKesson
MCK
|
$86.83 B |
0.003 M
|
![]() USA
|
![]() Teladoc Health
TDOC
|
$1.25 B |
0.000 M
|
![]() USA
|
![]() Veeva Systems
VEEV
|
$36.24 B |
-0.000 M
|
![]() USA
|
![]() Omnicell
OMCL
|
$1.47 B |
-0.000 M
|
![]() USA
|
![]() Evolent Health
EVH
|
$1.08 B |
-0.000 M
|
![]() USA
|
Market Cap | = | HCAT Stock Price | * | HCAT Shares Outstanding |
= | $3.70 | * | 70.21 M | |
= | $0.26 B |